Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lou-Gehrigs Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00386464
What this trial is testing

Noninvasive Ventilation in ALS Patients With Mild Respiratory Involvement

Who this might be right for
Amyotrophic Lateral Sclerosis
Johns Hopkins University 60
Testing effectiveness (Phase 2)WithdrawnNCT00561366
What this trial is testing

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
CytRx
Testing effectiveness (Phase 2)Ended earlyNCT04326283
What this trial is testing

Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Genuv Inc. 23
Testing effectiveness (Phase 2)Study completedNCT00647296
What this trial is testing

Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 194
Not applicableNo Longer AvailableNCT06069934
What this trial is testing

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

Who this might be right for
Amyotrophic Lateral Sclerosis
Prilenia
Early research (Phase 1)Looking for participantsNCT07401121
What this trial is testing

Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Celosia Therapeutics Pty Ltd 15
Not applicableLooking for participantsNCT06649955
What this trial is testing

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

Who this might be right for
ALS - Amyotrophic Lateral Sclerosis
PathMaker Neurosystems Inc. 15
Large-scale testing (Phase 3)Study completedNCT00573443
What this trial is testing

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

Who this might be right for
Pseudobulbar Affect (PBA)
Avanir Pharmaceuticals 326
Post-approval studies (Phase 4)Study completedNCT01811355
What this trial is testing

Mexiletine for the Treatment of Muscle Cramps in ALS

Who this might be right for
Muscle Cramps in Amyotrophic Lateral Sclerosis
Bjorn Oskarsson, MD 23
Testing effectiveness (Phase 2)Study completedNCT00072709
What this trial is testing

Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Novartis Pharmaceuticals 551
Large-scale testing (Phase 3)Study completedNCT00706147
What this trial is testing

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Miami 38
Testing effectiveness (Phase 2)Ended earlyNCT04428775
What this trial is testing

A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease

Who this might be right for
Amyotrophic Lateral Sclerosis
AZTherapies, Inc. 12
Large-scale testing (Phase 3)Study completedNCT01281189
What this trial is testing

Phase 3 Study of Dexpramipexole in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 942
Large-scale testing (Phase 3)Looking for participantsNCT03127267
What this trial is testing

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
AB Science 495
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07688239
What this trial is testing

The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)ALS - Amyotrophic Lateral SclerosisALS
Tiziana Life Sciences LTD 44
Not applicableLooking for participantsNCT01772602
What this trial is testing

The National Amyotrophic Lateral Sclerosis Registry

Who this might be right for
Amyotrophic Lateral Sclerosis
Centers for Disease Control and Prevention 30,000
Not applicableStudy completedNCT03868345
What this trial is testing

Speech Analysis in ALS Patients

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig Disease
Barrow Neurological Institute 26
Testing effectiveness (Phase 2)Study completedNCT00956488
What this trial is testing

Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron DiseaseLou Gehrig's Disease
Wake Forest University Health Sciences 9
Large-scale testing (Phase 3)Active Not RecruitingNCT04297683
What this trial is testing

HEALEY ALS Platform Trial - Master Protocol

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 1,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT04055623
What this trial is testing

T-regulatory Cells in ALS

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
The Methodist Hospital Research Institute 12
Next Page